Sign In
test

Sean Tan

Stempoint Capital Lp

Assets Managed
$1.037B
Holdings
76
Last Quarter
2026 - Q1
Filed Date
14d ago
Growth Rate
77.81%(2Q avg: 47.33%)
Sustained Growth
3 quarters

Portfolio positions

This chart displays the top 10 holdings in Stempoint Capital Lp's 2026 - Q1 portfolio, based on their 13F SEC filing, out of a total of 76 positions.

Assets under management

The assets under management (AUM) of Stempoint Capital Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 3 quarters. As of the latest 13F SEC filing for 2026 - Q1, they manage 1.037B in assets, with a quarterly growth rate of 77.81% and a 2-quarter average growth rate of 47.33%. The portfolio is managed by Sean Tan, and others.

Portfolio holdings

InvestmentPortfolio %Reported Value
SRRK
Scholar Rock Holding Corp
Recent Activity
Increased 95.13%
9.94%
$102.986M↑ Call
2.271M shares@ $45.35 avg price
ABVX
Abivax Sa-adr
Recent Activity
Increased 60.19%
6.74%
$69.881M
627,582 shares@ $111.36 avg price
SNDX
Syndax Pharmaceuticals Inc
Recent Activity
Increased 103.94%
5.5%
$56.98M↑ Call
2.731M shares@ $20.87 avg price
RVMD
Revolution Medicines Inc
Recent Activity
Increased 1130.44%
5.39%
$55.827M↓ Put
763,264 shares@ $73.15 avg price
IMVT
Immunovant Inc
Recent Activity
Increased 162.5%
3.63%
$37.596M↑ Call
1.693M shares@ $22.21 avg price
PRAX
Praxis Precision Medicines I
Recent Activity
Increased 434.18%
3.5%
$36.257M
112,534 shares@ $322.2 avg price
MBX
Mbx Biosciences Inc
Recent Activity
Increased 1171.68%
2.88%
$29.818M
998,938 shares@ $29.86 avg price
MLYS
Mineralys Therapeutics Inc
Recent Activity
Increased 267.79%
2.79%
$28.898M
1.067M shares@ $27.09 avg price
ELVN
Enliven Therapeutics Inc
Recent Activity
New Position
2.75%
$28.494M
726,876 shares@ $39.21 avg price
CGON
Cg Oncology Inc
Recent Activity
New Position
2.69%
$27.833M
411,244 shares@ $67.69 avg price

1-10 of 76